{
    "title": "GSK buys 10% of CureVac in vaccine tech deal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8540059/GSK-10-stake-Germanys-CureVac-163-mln.html",
    "date": "2020-07-20",
    "keywords": [
        "curevac",
        "gsk",
        "deal",
        "covid19",
        "arno",
        "valuation",
        "stock",
        "market",
        "investment",
        "pushkala",
        "aripaka",
        "stake",
        "biotech",
        "company",
        "monday",
        "billionaire",
        "bill",
        "launch",
        "year",
        "vaccine",
        "maker",
        "companys",
        "raft",
        "future",
        "mrna",
        "acid",
        "chemical",
        "messenger",
        "response",
        "approach",
        "biontech",
        "partner",
        "pfizer",
        "moderna",
        "therapy",
        "curevacs",
        "experience",
        "expertise",
        "president",
        "pence",
        "gmt",
        "government",
        "month",
        "document",
        "june",
        "euros",
        "funding",
        "addition",
        "boost",
        "listing",
        "september",
        "bank",
        "credit",
        "suisse",
        "matter",
        "ipo",
        "financing",
        "comment",
        "milestone",
        "transaction",
        "research",
        "jagadeesh",
        "babu",
        "bengaluru",
        "caroline",
        "copley",
        "schuetze",
        "frankfurt",
        "editing",
        "vinay",
        "dwivedipatrick",
        "grahamjane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}